Drug-induced peripheral nerve palsy: a real-world study based on FAERS data from 2004 to the third quarter of 2024.

ABSTRACT:

Background

Peripheral nerve palsy is a prevalent clinical condition that significantly impairs patients' quality of life. To advance clinical practice and mitigate the risk of drug-induced peripheral nerve palsy, this study aimed to identify adverse drug reaction signals related to peripheral nerve palsy through data mining of the FDA Adverse Event Reporting System (FAERS). Timely detection of high-risk medications provides a crucial basis for enhancing the safety of clinical drug use.

Methods

Adverse events (AEs) related to peripheral nerve palsy between 2004 and the third quarter of 2024 were extracted from the FAERS database. To identify potential drug safety signals associated with peripheral nerve palsy, four established pharmacovigilance statistical methods were employ

SUBMITTER: Li Y 

PROVIDER: S-EPMC12823817 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature